Related Experiment Video
Updated: Dec 31, 2025
09:58
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
3.0K
Oncogenic ETS Factors in Prostate Cancer
Taylor R Nicholas1, Brady G Strittmatter2, Peter C Hollenhorst3
1Department of Biology, Indiana University, Bloomington, IN, USA.
Advances in Experimental Medicine and Biology
|January 5, 2020
Summary
Prostate cancer often involves ETS gene rearrangements, leading to abnormal ETS factor expression. Understanding these molecular mechanisms is key to developing targeted therapies for this common cancer subtype.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer exhibits unique chromosomal rearrangements creating fusion genes.
- TMPRSS2/ERG rearrangement is a common driver, affecting 50% of prostate tumors.
- ETS family transcription factors (ERG, ETV1, ETV4) are implicated in tumorigenesis.
Purpose of the Study:
- To review molecular mechanisms of ETS factor function in prostate cancer.
- To identify potential therapeutic targets for ETS gene rearrangement-positive prostate cancer.
- To describe strategies for targeting oncogenic ETS factors.
Main Methods:
- Review of current literature on ETS gene rearrangements in prostate cancer.
- Analysis of molecular mechanisms underlying ETS factor activity.
- Examination of therapeutic strategies targeting ETS factors.
Main Results:
- ETS gene rearrangements are prevalent in prostate cancer, defining a major molecular subtype.
- ETS factors play a critical role in prostate tumorigenesis.
- No specific treatments currently exist for ETS rearrangement-positive prostate cancer.
Conclusions:
- Understanding ETS factor molecular mechanisms is crucial for developing targeted therapies.
- Targeting ETS factors directly or indirectly offers a promising therapeutic avenue.
- Precision medicine approaches are needed for ETS gene rearrangement-positive prostate cancer.
More Related Videos
Related Concept Videos
01:33Cancer-Critical Genes I: Proto-oncogenes
11.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
02:38Mitogens and the Cell Cycle
7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
03:03mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
02:38The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K